R9Q Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Recce Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 0.176 EUR -0.56%

Market Cap: €39m

	Recce Pharmaceuticals Ltd F:R9Q	AU

Profitability Summary

Recce Pharmaceuticals Ltd's profitability score is 48/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-133%

Negative 3Y Average Operating Margin

-566%

Operating Margin is Increasing

-289% > -133%

Negative Net Margin

-151%

Negative 3Y Average Net Margin

-631%

Net Margin is Increasing

-295% > -151%

Negative Free Cash Flow Margin

-26%

Negative 3Y Average Free Cash Flow Margin

-123%

Free Cash Flow Margin is Increasing

-287% > -26%

Exceptional ROE

151%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-14 757%

ROIC is Increasing

-7 816% > 356%

View All

Hide

Collapse

48 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.